ArticleJournal of medicinal chemistry2022

Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer.

Meredith S Eno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.